{"SPADE_UN_26876": {"Sequence Information": {"Peptide Name": "Smp24 [S3,15K]", "Sequence": "IWKFLIKAATKLLPKLFGGGKKDS", "Sequence Length": 24, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anticancer", "Anti-Mammalian Cell"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [], "Literature": [{"Title": "Improving the Therapeutic Index of Smp24, a Venom-Derived Antimicrobial Peptide: Increased Activity against Gram-Negative Bacteria", "Pubmed ID": "35887325", "Reference": "Int J Mol Sci. 2022;23:7979", "Author": "Rawson KM, Lacey MM, Strong PN, Miller K", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/35887325"}], "Mass": 2660.25, "PI": 10.3, "Net Charge": 5, "Hydrophobicity": 0.05, "Frequent Amino Acids": "KLG", "Absent Amino Acids": "CEHMNOQRUVY", "Basic Residues": 6, "Acidic Residues": 1, "Hydrophobic Residues": 10, "Polar Residues": 14, "Positive Residues": 6, "Negative Residues": 1, "SPADE ID": "SPADE_UN_26876", "Similar Sequences": [{"SPADE_ID": "SPADE_UN_26876", "Similarity": 1.0, "Sequence": "IWKFLIKAATKLLPKLFGGGKKDS"}, {"SPADE_ID": "SPADE_N_14338", "Similarity": 0.9583333333333334, "Sequence": "IWKFLIKAATKLLPSLFGGGKKDS"}, {"SPADE_ID": "SPADE_UN_26875", "Similarity": 0.9583333333333334, "Sequence": "IWKFLIKAATKLLPSLFGGGKKDS"}], "Hemolytic Activity": "Human embryonic kidney HEK293 cells:LD50=29 µg/ml,Sheep erythrocytes:50% Hemolysis=23 µg/ml", "Target Organism": "Human hepatocellular carcinoma HepG2(LD50=42µg/ml),Escherichia coli JM109(MIC=16µg/ml),Escherichia coli JM109(MBC=16µg/ml),Pseudomonas aeruginosa H085180216(MIC=16µg/ml),Pseudomonas aeruginosa H085180216(MBC=32µg/ml),Staphylococcus aureus SH1000(MIC=16µg/ml),Staphylococcus aureus SH1000(MBC=16µg/ml)"}}}